Hyperinflammation in COVID-19 Obese Patients Treated With Tocilizumab: A Successful Case Series

The cytokine storm syndrome has been suggested as a mechanism in the pathophysiology of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2; COVID-19 [coronavirus disease 2019]) infection. Drugs such as tocilizumab, an interleukin-6 antagonist, have shown good results in other scenarios of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltrão, Beatriz Amorim, Teixeira, Rafael Cabral, Porto, Diego Bastos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326622/
https://www.ncbi.nlm.nih.gov/pubmed/34334015
http://dx.doi.org/10.1177/23247096211037442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326622/
https://www.ncbi.nlm.nih.gov/pubmed/34334015
http://dx.doi.org/10.1177/23247096211037442

Ejemplares similares